Dong Tang1, Jun Gao1, Sen Wang2, Nianyuan Ye1, Yang Chong1, Yuqin Huang1, Jie Wang1, Bin Li1, Wei Yin1, Daorong Wang3. 1. Department of Gastrointestinal Surgery, Clinical Medical College of Yangzhou University (Subei People's Hospital of Jiangsu Province), Yangzhou, 225001, People's Republic of China. 2. College of Clinical Medicine, Nanjing Medical University (the First Affiliated Hospital of Nanjing Medical University), Nanjing, 211166, People's Republic of China. 3. Department of Gastrointestinal Surgery, Clinical Medical College of Yangzhou University (Subei People's Hospital of Jiangsu Province), Yangzhou, 225001, People's Republic of China. daorong666@sina.com.
Abstract
BACKGROUND: Galectin-1, an evolutionarily conserved glycan-binding protein with angiogenic potential, was recently identified as being overexpressed in cancer-associated fibroblasts (CAFs) of gastric cancer. The role of endogenous CAF-derived galectin-1 on angiogenesis in gastric cancer and the mechanism involved remain unknown. METHODS: Immunohistochemical staining was used to investigate the correlation between galectin-1 and vascular endothelial growth factor (VEGF) and CD31 expression in gastric cancer tissues and normal gastric tissues. Galectin-1 was knocked down in CAFs isolated from gastric cancer using small interfering ribonucleic acid (RNA), or overexpressed using recombinant lentiviruses, and the CAFs were co-cultured with human umbilical vein endothelial cells (HUVECs) or cancer cells. Subsequently, proliferation, migration, tube formation, and VEGF/VEGF receptor (VEGFR) 2 expression were detected. The role of CAF-derived galectin-1 in tumor angiogenesis in vivo was studied using the chick chorioallantoic membrane (CAM) assay. RESULTS: Galectin-1 was highly expressed in the CAFs and was positively associated with VEGF and CD31 expression. In the co-culture, high expression of galectin-1 in the CAFs increased HUVEC proliferation, migration, tube formation, and VEGFR2 phosphorylation and enhanced VEGF expression in gastric cancer cells. The CAM assay indicated that high expression of galectin-1 in the CAFs accelerated tumor growth and promoted angiogenesis. In contrast, galectin-1 knockdown in the CAFs significantly inhibited this effect. CONCLUSION: CAF-derived galectin-1 significantly promotes angiogenesis in gastric cancer and may be a target for angiostatic therapy.
BACKGROUND:Galectin-1, an evolutionarily conserved glycan-binding protein with angiogenic potential, was recently identified as being overexpressed in cancer-associated fibroblasts (CAFs) of gastric cancer. The role of endogenous CAF-derived galectin-1 on angiogenesis in gastric cancer and the mechanism involved remain unknown. METHODS: Immunohistochemical staining was used to investigate the correlation between galectin-1 and vascular endothelial growth factor (VEGF) and CD31 expression in gastric cancer tissues and normal gastric tissues. Galectin-1 was knocked down in CAFs isolated from gastric cancer using small interfering ribonucleic acid (RNA), or overexpressed using recombinant lentiviruses, and the CAFs were co-cultured with human umbilical vein endothelial cells (HUVECs) or cancer cells. Subsequently, proliferation, migration, tube formation, and VEGF/VEGF receptor (VEGFR) 2 expression were detected. The role of CAF-derived galectin-1 in tumor angiogenesis in vivo was studied using the chick chorioallantoic membrane (CAM) assay. RESULTS:Galectin-1 was highly expressed in the CAFs and was positively associated with VEGF and CD31 expression. In the co-culture, high expression of galectin-1 in the CAFs increased HUVEC proliferation, migration, tube formation, and VEGFR2 phosphorylation and enhanced VEGF expression in gastric cancer cells. The CAM assay indicated that high expression of galectin-1 in the CAFs accelerated tumor growth and promoted angiogenesis. In contrast, galectin-1 knockdown in the CAFs significantly inhibited this effect. CONCLUSION: CAF-derived galectin-1 significantly promotes angiogenesis in gastric cancer and may be a target for angiostatic therapy.
Entities:
Keywords:
Angiogenesis; Cancer-associated fibroblasts; Galectin-1; Gastric cancer
Authors: Alain Vonlaufen; Swapna Joshi; Changfa Qu; Phoebe A Phillips; Zhihong Xu; Nicole R Parker; Cheryl S Toi; Romano C Pirola; Jeremy S Wilson; David Goldstein; Minoti V Apte Journal: Cancer Res Date: 2008-04-01 Impact factor: 12.701
Authors: S H Hsieh; N W Ying; M H Wu; W F Chiang; C L Hsu; T Y Wong; Y T Jin; T M Hong; Y L Chen Journal: Oncogene Date: 2008-01-28 Impact factor: 9.867
Authors: Silvia Balabanova; Chris Holmberg; Islay Steele; Bahram Ebrahimi; Lucille Rainbow; Ted Burdyga; Cathy McCaig; Lazso Tiszlavicz; Nantaporn Lertkowit; Olivier T Giger; Simon Oliver; Ian Prior; Rod Dimaline; Deborah Simpson; Rob Beynon; Peter Hegyi; Timothy C Wang; Graham J Dockray; Andrea Varro Journal: Carcinogenesis Date: 2014-04-07 Impact factor: 4.944
Authors: Elizabete Bagordakis; Iris Sawazaki-Calone; Carolina Carneiro Soares Macedo; Carolina M Carnielli; Carine Ervolino de Oliveira; Priscila Campioni Rodrigues; Ana Lucia C A Rangel; Jean Nunes Dos Santos; Juha Risteli; Edgard Graner; Tuula Salo; Adriana Franco Paes Leme; Ricardo D Coletta Journal: Tumour Biol Date: 2016-01-13
Authors: Alessandra Toti; Alice Santi; Elisa Pardella; Ilaria Nesi; Richard Tomasini; Tommaso Mello; Paolo Paoli; Anna Caselli; Paolo Cirri Journal: J Cell Commun Signal Date: 2021-05-22 Impact factor: 5.782